Showing results (1-10 of 43) with videos related to
Sort By:
Pageof 5
Current Medicinal Chemistry. Cardiovascular and Hematological Agents|August 24, 2004
Atherosclerosis -- new targets and therapeuticsSivaram Pillarisetti, Christopher W Alexander, Uday SaxenaExpert Opinion on Therapeutic Targets|October 8, 2004
Role of oxidative stress and inflammation in the origin of Type 2 diabetes--a paradigm shiftSivaram Pillarisetti, Uday SaxenaFrontiers in Bioscience : a Journal and Virtual Library|November 29, 2002
Lipoprotein lipase as a therapeutic target for dyslipidemiaSivaram Pillarisetti, Uday SaxenaExpert Opinion on Therapeutic Targets|January 24, 2003
New approaches for treatment of diabetic nephropathy: the endothelium as a target for drug discoveryUday Saxena, Richard T Timmer, Sivaram PillarisettiDiabetes|December 17, 2008
Lipoic acid synthase (LASY): a novel role in inflammation, mitochondrial function, and insulin resistanceIndira Padmalayam, Sumera Hasham, Uday Saxena, et al.The Journal of Biological Chemistry|April 8, 2006
Novel anti-inflammatory role for glycogen synthase kinase-3beta in the inhibition of tumor necrosis factor-alpha- and interleukin-1beta-induced inflammatory gene expressionAngela Vines, Sientay Cahoon, Ira Goldberg, et al.Drug Discovery Today|September 1, 2009
Pain and beyond: fatty acid amides and fatty acid amide hydrolase inhibitors in cardiovascular and metabolic diseasesSivaram Pillarisetti, Christopher W Alexander, Ish KhannaBiochemistry|April 28, 2004
Inflammatory cytokines and fatty acids regulate endothelial cell heparanase expressionGuangping Chen, Dongyan Wang, Reeba Vikramadithyan, et al.Cardiovascular & Hematological Agents in Medicinal Chemistry|May 29, 2012
Thematic issue-topic--diabetic cardiovascular disease--an unmet medical need: emerging targets and therapies-introduction to the special issueSivaram PillarisettiTrends in Pharmacological Sciences|January 1, 2016
Potential Drug Combinations to Reduce Cardiovascular Disease Burden in DiabetesSivaram PillarisettiPageof 5